(Q83139773)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Frederik A Verburg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Uwe Mäder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Markus Luster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Christoph Reiners

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Heribert Hänscheid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

6 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

673-680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-010-1689-5

19 January 2020

exact match

0 references

cites work

Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients

1 reference

12 December 2020

American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules

1 reference

12 December 2020

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal

1 reference

12 December 2020

Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma

1 reference

12 December 2020

Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients

1 reference

12 December 2020

Thyroid stunning in vivo and in vitro

1 reference

12 December 2020

A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer

1 reference

12 December 2020

Guidelines for radioiodine therapy of differentiated thyroid cancer

1 reference

12 December 2020

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

12 December 2020

Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.

1 reference

12 December 2020

ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?

1 reference

12 December 2020

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

1 reference

12 December 2020

[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]

1 reference

12 December 2020

Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients

1 reference

12 December 2020

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants

1 reference

12 December 2020

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study

1 reference

12 December 2020

A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.

1 reference

12 December 2020

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

12 December 2020

The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies

1 reference

12 December 2020

131I effective half-life and dosimetry in thyroid cancer patients.

1 reference

12 December 2020

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin

1 reference

12 December 2020

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

1 reference

12 December 2020

Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.

1 reference

12 December 2020

Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy

1 reference

12 December 2020

An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer

1 reference

12 December 2020

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

1 reference

12 December 2020

Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation

1 reference

12 December 2020

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma

1 reference

12 December 2020

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

1 reference

12 December 2020

The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I.

1 reference

12 December 2020

Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome

1 reference

12 December 2020

Dosimetry and thyroid cancer: the individual dosage of radioiodine

1 reference

12 December 2020

Individualized dosimetry in the management of metastatic differentiated thyroid cancer

1 reference

12 December 2020

10.1007/S00259-010-1689-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21210115%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference